Lluís Force

2.2k total citations
28 papers, 925 citations indexed

About

Lluís Force is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Lluís Force has authored 28 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Virology. Recurrent topics in Lluís Force's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (9 papers). Lluís Force is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (9 papers). Lluís Force collaborates with scholars based in Spain, United Kingdom and France. Lluís Force's co-authors include Mateu Serra‐Prat, Elísabet Palomera, Père Clavé, Montserrat Cabré i Pairet, Jordi Almirall, Peré Domingo, Enric Pedrol, Bonaventura Clotet, Ferrán Segura and Josep M. Llibre and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lluís Force

26 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lluís Force Spain 17 533 322 279 232 149 28 925
Andrew Riordan United Kingdom 20 638 1.2× 157 0.5× 696 2.5× 130 0.6× 49 0.3× 67 1.3k
Élise Arrivé France 20 701 1.3× 292 0.9× 270 1.0× 134 0.6× 54 0.4× 42 1.2k
Antoni Noguera‐Julián Spain 20 821 1.5× 328 1.0× 655 2.3× 362 1.6× 24 0.2× 125 1.5k
Murli Purswani United States 21 547 1.0× 219 0.7× 226 0.8× 309 1.3× 29 0.2× 46 1.0k
Susan Bersoff‐Matcha United States 13 523 1.0× 158 0.5× 305 1.1× 168 0.7× 11 0.1× 21 1.1k
Carol Worrell United States 16 613 1.2× 217 0.7× 401 1.4× 323 1.4× 16 0.1× 19 974
Emanuele Palomba Italy 13 408 0.8× 216 0.7× 237 0.8× 127 0.5× 12 0.1× 44 829
Pablo Rojo Spain 19 593 1.1× 299 0.9× 320 1.1× 247 1.1× 18 0.1× 83 1.1k
Larry Bernstein United States 16 340 0.6× 275 0.9× 415 1.5× 128 0.6× 15 0.1× 35 1.1k
Leslie Serchuck United States 16 508 1.0× 213 0.7× 361 1.3× 144 0.6× 10 0.1× 19 790

Countries citing papers authored by Lluís Force

Since Specialization
Citations

This map shows the geographic impact of Lluís Force's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluís Force with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluís Force more than expected).

Fields of papers citing papers by Lluís Force

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluís Force. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluís Force. The network helps show where Lluís Force may publish in the future.

Co-authorship network of co-authors of Lluís Force

This figure shows the co-authorship network connecting the top 25 collaborators of Lluís Force. A scholar is included among the top collaborators of Lluís Force based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluís Force. Lluís Force is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campins, Lluís, et al.. (2020). Early tocilizumab treatment could improve survival among COVID-19 patients.. Clinical and Experimental Rheumatology. 38(3). 578–578. 24 indexed citations
2.
Llibre, Josep M., Alexandra Montoliu, JM Miró, et al.. (2019). Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort. HIV Medicine. 20(3). 237–247. 25 indexed citations
3.
Reyes‐Urueña, Juliana, Colin Campbell, Anna Esteve, et al.. (2018). Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population. BMJ Open. 8(2). e018533–e018533. 16 indexed citations
4.
Campbell, Colin, Juan Ambrosioni, José M. Miró, et al.. (2015). The continuum of HIV care in Catalonia. AIDS Care. 27(12). 1449–1454. 12 indexed citations
5.
Santos, José Ramón, José Luís Blanco, Mar Masiá, et al.. (2015). Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences. Journal of Antimicrobial Chemotherapy. 70(11). 3087–3095. 12 indexed citations
6.
Ja, Capdevila, Pilar Barrufet, Lluís Force, et al.. (2015). Mortality among methicillin-resistant Staphylococcus aureus carriers in long-term care facilities.. PubMed. 28(2). 92–7. 7 indexed citations
7.
Force, Lluís, Goretti Sauca, Sarai Rodríguez, et al.. (2014). Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in an acute care hospital and long-term care facilities located in the same geographic area.. PubMed. 27(3). 190–5. 10 indexed citations
8.
Pairet, Montserrat Cabré i, Mateu Serra‐Prat, Lluís Force, et al.. (2013). Oropharyngeal Dysphagia is a Risk Factor for Readmission for Pneumonia in the Very Elderly Persons: Observational Prospective Study. The Journals of Gerontology Series A. 69A(3). 330–337. 150 indexed citations
9.
10.
Negredo, Eugènia, Óscar Miró, Glòria Garrabou, et al.. (2009). Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse‐Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). Clinical Infectious Diseases. 49(6). 892–900. 36 indexed citations
11.
Jaén, Ángeles, Anna Esteve, Josep M. Miró, et al.. (2008). Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2). 212–220. 44 indexed citations
12.
Cabré, Mateu, Mateu Serra‐Prat, Lluís Force, Elísabet Palomera, & Román Pallarés. (2008). Functional status as a risk factor for mortality in very elderly patients with pneumonia. Medicina Clínica. 131(5). 167–170. 37 indexed citations
13.
Navarro, Gemma, María Mercedes Nogueras, F. Segura, et al.. (2008). HIV-1 infected patients older than 50 years. PISCIS cohort study. Journal of Infection. 57(1). 64–71. 32 indexed citations
14.
Solà, Ricard, Silvia Montoliu, Cristina Tural, et al.. (2006). Poor Response to Hepatitis C Virus (HCV) Therapy in HIV- and HCV-Coinfected Patients Is Not Due to Lower Adherence to Treatment. AIDS Research and Human Retroviruses. 22(5). 393–400. 20 indexed citations
15.
Bonjoch, Anna, Roger Paredes, Peré Domingo, et al.. (2006). Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients. AIDS Research and Human Retroviruses. 22(4). 321–329. 28 indexed citations
16.
Ballarín, Elena, Luisa Ibáñez, José‐Ángel Hernández‐Rivas, Lluís Force, & Joan‐Ramon Laporte. (2005). Cyanamide-induced aplastic anemia. European Journal of Clinical Pharmacology. 61(5-6). 467–469.
17.
Fuster, Daniel, Guadalupe Gómez Melis, Ricard Solà, et al.. (2005). Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy. Antiviral Therapy. 10(7). 841–847. 17 indexed citations
18.
Almeda, Jesús, Jordi Casabona, Alejandro Allepuz, et al.. (2002). Recomendaciones para la profilaxis postexposición no ocupacional al VIH. Enfermedades Infecciosas y Microbiología Clínica. 20(8). 391–400. 12 indexed citations
19.
Queralt, Cristina, et al.. (1998). Osteonecrosis and HIV infection: 4 more cases.. PubMed. 25(6). 1243–4. 14 indexed citations
20.
Grapperon, Jacques, et al.. (1988). Effects of high pressure on nervous conduction velocity in man. European Journal of Applied Physiology. 58(1-2). 141–145. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Riordan Breakdown of academic impact, for papers by Élise Arrivé Breakdown of academic impact, for papers by Antoni Noguera‐Julián Breakdown of academic impact, for papers by Murli Purswani Breakdown of academic impact, for papers by Susan Bersoff‐Matcha Breakdown of academic impact, for papers by Carol Worrell Breakdown of academic impact, for papers by Emanuele Palomba Breakdown of academic impact, for papers by Pablo Rojo Breakdown of academic impact, for papers by Larry Bernstein Breakdown of academic impact, for papers by Leslie Serchuck
Rankless by CCL
2026